• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从代谢健康到不健康表型的转变与 BMI 类别中 90257 名女性心血管疾病风险的关系:前瞻性队列研究 30 年随访。

Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.

机构信息

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; German Center for Diabetes Research (DZD), München-Neuherberg, Germany; University of Potsdam, Institute of Nutritional Sciences, Nuthetal, Germany.

Department of Nutrition, Harvard T H Chan School of Public Health, Boston, MA, USA.

出版信息

Lancet Diabetes Endocrinol. 2018 Sep;6(9):714-724. doi: 10.1016/S2213-8587(18)30137-2. Epub 2018 May 31.

DOI:10.1016/S2213-8587(18)30137-2
PMID:29859908
Abstract

BACKGROUND

Cardiovascular disease risk among individuals across different categories of BMI might depend on their metabolic health. It remains unclear to what extent metabolic health status changes over time and whether this affects cardiovascular disease risk. In this study, we aimed to examine the association between metabolic health and its change over time and cardiovascular disease risk across BMI categories.

METHODS

Between June and December, 1976, 121 701 female nurses were recruited to the Nurses' Health Study (NHS) of whom 103 298 returned a questionnaire in 1980 used as baseline in this study. After excluding women with a history of cardiovascular disease or cancer, with missing body weight and with underweight. 90 257 women were followed-up from 1980 to 2010 for incident cardiovascular disease. Participants were cross-classified by BMI categories, metabolic health (defined by absence of diabetes, hypertension and hypercholesterolaemia), and change in metabolic health status during follow-up. The cardiovascular component of the NHS is registered with ClinicalTrials.gov, number NCT00005152.

FINDINGS

During 2 127  391 person-years of follow-up with a median follow-up of 24 years, we documented 6306 cases of cardiovascular disease including 3304 myocardial infarction cases and 3080 strokes. Cardiovascular disease risk of women with metabolically healthy obesity was increased compared with women with metabolically healthy normal weight (HR 1·39, 95% CI 1·15-1·68), but risk was considerably higher in women with metabolically unhealthy normal weight (2·43, 2·19-2·68), overweight (2·61, 2·36-2·89) and obesity (3·15, 2·83-3·50). The majority of metabolically healthy women converted to unhealthy phenotypes (2555 [84%] of 3027 women with obesity, 22 215 [68%] of 32 882 women with normal-weight after 20 years). Women who maintained metabolically healthy obesity during follow-up were still at a higher cardiovascular disease risk compared with women with stable healthy normal weight (HR 1·57, 1·03-2·38), yet this risk was lower than for initially metabolically healthy women who converted to an unhealthy phenotype (normal-weight 1·90, 1·66-2·17 vs obesity 2·74, 2·30-3·27). Particularly incident diabetes and hypertension increased the risk among women with initial metabolic health.

INTERPRETATION

Even when metabolic health is maintained during long periods of time, obesity remains a risk factor for cardiovascular disease. However, risks are highest for metabolically unhealthy women across all BMI categories. A large proportion of metabolically healthy women converted to an unhealthy phenotype over time across all BMI categories, which is associated with an increased cardiovascular disease risk.

FUNDING

US National Institutes of Health, German Federal Ministry of Education and Research.

摘要

背景

不同 BMI 类别的个体的心血管疾病风险可能取决于其代谢健康状况。代谢健康状况随时间的变化程度以及这是否影响心血管疾病风险仍不清楚。在这项研究中,我们旨在研究代谢健康及其随时间的变化与 BMI 类别之间的心血管疾病风险之间的关联。

方法

1976 年 6 月至 12 月,招募了 121701 名女护士参加护士健康研究(NHS),其中 103298 名护士在 1980 年返回了一份问卷,作为本研究的基线。排除了有心血管疾病或癌症病史、体重缺失和体重不足的妇女。在 1980 年至 2010 年期间,90257 名女性因心血管疾病发病而接受随访。参与者按 BMI 类别、代谢健康状况(定义为无糖尿病、高血压和高胆固醇血症)和随访期间代谢健康状况的变化进行交叉分类。NHS 的心血管部分在 ClinicalTrials.gov 注册,编号为 NCT00005152。

结果

在 2127391 人年的中位随访时间为 24 年的随访期间,我们记录了 6306 例心血管疾病,包括 3304 例心肌梗死和 3080 例中风。与代谢健康的正常体重女性相比,肥胖且代谢健康的女性的心血管疾病风险增加(HR 1.39,95%CI 1.15-1.68),但与代谢不健康的正常体重女性(2.43,2.19-2.68)、超重(2.61,2.36-2.89)和肥胖(3.15,2.83-3.50)相比,风险更高。大多数代谢健康的女性转变为不健康的表型(3027 名肥胖女性中有 2555 名[84%],32882 名正常体重女性中有 22215 名[68%]在 20 年后)。与稳定的健康正常体重女性相比,在随访期间保持代谢健康肥胖的女性仍处于更高的心血管疾病风险(HR 1.57,1.03-2.38),但这一风险低于最初具有代谢健康且转变为不健康表型的女性(正常体重 1.90,1.66-2.17 与肥胖 2.74,2.30-3.27)。最初的代谢健康女性中,特别是新发糖尿病和高血压会增加女性的风险。

解释

即使在长时间内保持代谢健康,肥胖仍然是心血管疾病的一个危险因素。然而,在所有 BMI 类别中,代谢不健康的女性风险最高。随着时间的推移,大量代谢健康的女性在所有 BMI 类别中转变为不健康的表型,这与心血管疾病风险增加有关。

资金

美国国立卫生研究院,德国联邦教育和研究部。

相似文献

1
Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.从代谢健康到不健康表型的转变与 BMI 类别中 90257 名女性心血管疾病风险的关系:前瞻性队列研究 30 年随访。
Lancet Diabetes Endocrinol. 2018 Sep;6(9):714-724. doi: 10.1016/S2213-8587(18)30137-2. Epub 2018 May 31.
2
Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study.代谢健康型肥胖、向不健康代谢状态转变与中国成年人血管疾病:队列研究。
PLoS Med. 2020 Oct 30;17(10):e1003351. doi: 10.1371/journal.pmed.1003351. eCollection 2020 Oct.
3
Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.代谢健康表型的自然病程及发生心血管代谢疾病的风险:一项为期三年的随访研究。
BMC Endocr Disord. 2021 Apr 28;21(1):85. doi: 10.1186/s12902-021-00754-1.
4
A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).欧洲癌症与营养前瞻性调查(EPIC)中代谢定义的体型表型与结直肠癌风险的巢式病例对照研究。
PLoS Med. 2016 Apr 5;13(4):e1001988. doi: 10.1371/journal.pmed.1001988. eCollection 2016 Apr.
5
Metabolically healthy obesity, transition from metabolic healthy to unhealthy status, and carotid atherosclerosis.代谢健康型肥胖、代谢健康向不健康状态的转变与颈动脉粥样硬化。
Diabetes Metab Res Rev. 2024 Feb;40(2):e3766. doi: 10.1002/dmrr.3766.
6
Transition in metabolic health phenotypes across general adiposity categories and association with the risk of depression: a prospective analysis.在一般肥胖类别中代谢健康表型的转变与抑郁症风险的关联:一项前瞻性分析。
Eur Psychiatry. 2024 Feb 29;67(1):e26. doi: 10.1192/j.eurpsy.2024.20.
7
Association between metabolic phenotypes of overweight/obesity and cardiovascular diseases in postmenopausal women.超重/肥胖的代谢表型与绝经后妇女心血管疾病的关系。
Nutr Metab Cardiovasc Dis. 2024 Nov;34(11):2562-2569. doi: 10.1016/j.numecd.2024.04.001. Epub 2024 Apr 5.
8
Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population.老年人群中代谢健康型肥胖与心血管疾病风险
PLoS One. 2016 Apr 21;11(4):e0154273. doi: 10.1371/journal.pone.0154273. eCollection 2016.
9
Different Metabolic Phenotypes of Obesity and Risk of Coronary Artery Calcium Progression and Incident Cardiovascular Disease Events: The CARDIA Study.肥胖的不同代谢表型与冠状动脉钙化进展及心血管疾病事件发生风险:CARDIA研究
Arterioscler Thromb Vasc Biol. 2022 May;42(5):677-688. doi: 10.1161/ATVBAHA.122.317526. Epub 2022 Apr 7.
10
Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank.在中国 500 万成年人中,代谢健康型肥胖、向不健康表型转变与 2 型糖尿病:中国科克伦协作生物样本库研究。
Eur J Endocrinol. 2022 Jan 6;186(2):233-244. doi: 10.1530/EJE-21-0743.

引用本文的文献

1
Associations of metabolic heterogeneity of obesity with the progression of cardiometabolic multimorbidity-a nationwide prospective cohort study.肥胖代谢异质性与心血管代谢多重疾病进展的关联——一项全国性前瞻性队列研究
Front Nutr. 2025 Aug 21;12:1617929. doi: 10.3389/fnut.2025.1617929. eCollection 2025.
2
Perirenal fat: a neglected fat depot shaping heterogeneity of obesity along with hepatic fat.肾周脂肪:一个被忽视的脂肪库,与肝脏脂肪共同塑造肥胖的异质性。
Int J Obes (Lond). 2025 Aug 26. doi: 10.1038/s41366-025-01874-7.
3
Disentangling consequences of self-perceived weight from excess adiposity in metabolically healthy overweight/obesity.
解析代谢健康的超重/肥胖人群中自我认知体重与过量脂肪的后果。
BMC Public Health. 2025 Aug 25;25(1):2907. doi: 10.1186/s12889-025-24254-2.
4
Association of obesity phenotypes with risk of cardiovascular disease mortality: a prospective cohort study.肥胖表型与心血管疾病死亡风险的关联:一项前瞻性队列研究。
BMC Public Health. 2025 Jul 15;25(1):2464. doi: 10.1186/s12889-025-23628-w.
5
Genomics reveals eleven obesity endotypes with distinct biological and phenotypic signatures.基因组学揭示了具有不同生物学和表型特征的11种肥胖内型。
medRxiv. 2025 Jul 2:2025.06.30.25330607. doi: 10.1101/2025.06.30.25330607.
6
The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity.瑞他鲁肽对2型糖尿病和/或肥胖症参与者肾脏参数的影响。
Kidney Int Rep. 2025 Apr 2;10(6):1980-1992. doi: 10.1016/j.ekir.2025.03.049. eCollection 2025 Jun.
7
Prevalence of kidney stones based on metabolic health and weight criteria: reports from the national health and nutrition examination survey 2007-2018 data analysis.基于代谢健康和体重标准的肾结石患病率:来自2007 - 2018年国家健康与营养检查调查数据分析的报告
Front Physiol. 2025 Jun 23;16:1625100. doi: 10.3389/fphys.2025.1625100. eCollection 2025.
8
Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study.糖化血红蛋白指数与早期心血管-肾脏-代谢综合征患者心血管疾病风险的关联:来自中国健康与养老追踪调查的证据
Front Endocrinol (Lausanne). 2025 May 8;16:1554032. doi: 10.3389/fendo.2025.1554032. eCollection 2025.
9
Metabolically healthy abdominal obesity is associated with higher odds of left ventricular geometric remodeling in children: Evidence from two school-based studies in China.代谢健康的腹型肥胖与儿童左心室几何重构几率较高相关:来自中国两项基于学校研究的证据。
Int J Obes (Lond). 2025 May 22. doi: 10.1038/s41366-025-01800-x.
10
Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression.代谢健康型肥胖与代谢功能障碍相关脂肪性肝病(MASLD):应对疾病发生发展中的争议
Curr Obes Rep. 2025 May 19;14(1):46. doi: 10.1007/s13679-025-00637-9.